A Takeda spokesperson told Fierce Biotech that it was on track to open its new R&D facility being developed by BioMed Realty ...
Madrigal Pharmaceuticals is continuing to splash the cash this year on liver disease drugs it can combine with its own potential blockbuster Rezdiffra. | Madrigal Pharmaceuticals is continuing to ...
Following Moderna's public rebuke of the FDA's refusal to take up its application for a next-gen flu vaccine, the regulator has doubled down and accused Moderna of potentially putting patients at risk ...
GE HealthCare has launched a new technology designed to help hospitals keep up with the maintenance and repair demands of a growing number of connected medical devices. | GE HealthCare has launched a ...
A phase 2 asthma study of Upstream Bio’s TSLP receptor agonist has hit its primary endpoint. But with only the 12-week regimen achieving a Tezspire-like reduction in the annualized asthma exacerbation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results